Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Sherman

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|March 24, 2004
Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteriaRanjana Mehta, Josh T Pearson, Sumit Mahajan, et al.
Nature Medicine|February 3, 2009
A replication clock for Mycobacterium tuberculosisWendy P Gill, Nada S Harik, Molly R Whiddon, et al.
Annual Review of Genetics|September 14, 2020
Genetic Diversity in <i>Mycobacterium tuberculosis</i> Clinical Isolates and Resulting Outcomes of Tuberculosis Infection and DiseaseJulian S Peters, Nabila Ismail, Anzaan Dippenaar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2012
Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responsesXisheng Wang, Peter F Barnes, Fangfang Huang, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductaseA'Lissa B Gerum, Jonathan E Ulmer, David P Jacobus, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Netupitant Exhibits Potent Activity on <i>Mycobacterium tuberculosis</i> PersistersHassan E Eldesouky, Richard M Jones, Natalie Gleason, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
Rapidly Correcting Frameshift Mutations in the Mycobacterium tuberculosis <i>orn</i> Gene Produce Reversible Ethambutol Resistance and Small-Colony-Variant MorphologyHassan Safi, Subramanya Lingaraju, Shuyi Ma, et al.
The Journal of Infectious Diseases|January 1, 2003
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuationKaeryn N Lewis, Reiling Liao, Kristi M Guinn, et al.
Plos Computational Biology|December 1, 2015
Integrated Modeling of Gene Regulatory and Metabolic Networks in Mycobacterium tuberculosisShuyi Ma, Kyle J Minch, Tige R Rustad, et al.
Plos One|July 7, 2012
High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activityAnuradha Kumar, Meng Zhang, Linyun Zhu, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|March 24, 2004
Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteriaRanjana Mehta, Josh T Pearson, Sumit Mahajan, et al.
Nature Medicine|February 3, 2009
A replication clock for Mycobacterium tuberculosisWendy P Gill, Nada S Harik, Molly R Whiddon, et al.
Annual Review of Genetics|September 14, 2020
Genetic Diversity in <i>Mycobacterium tuberculosis</i> Clinical Isolates and Resulting Outcomes of Tuberculosis Infection and DiseaseJulian S Peters, Nabila Ismail, Anzaan Dippenaar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2012
Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responsesXisheng Wang, Peter F Barnes, Fangfang Huang, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductaseA'Lissa B Gerum, Jonathan E Ulmer, David P Jacobus, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Netupitant Exhibits Potent Activity on <i>Mycobacterium tuberculosis</i> PersistersHassan E Eldesouky, Richard M Jones, Natalie Gleason, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
Rapidly Correcting Frameshift Mutations in the Mycobacterium tuberculosis <i>orn</i> Gene Produce Reversible Ethambutol Resistance and Small-Colony-Variant MorphologyHassan Safi, Subramanya Lingaraju, Shuyi Ma, et al.
The Journal of Infectious Diseases|January 1, 2003
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuationKaeryn N Lewis, Reiling Liao, Kristi M Guinn, et al.
Plos Computational Biology|December 1, 2015
Integrated Modeling of Gene Regulatory and Metabolic Networks in Mycobacterium tuberculosisShuyi Ma, Kyle J Minch, Tige R Rustad, et al.
Plos One|July 7, 2012
High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activityAnuradha Kumar, Meng Zhang, Linyun Zhu, et al.
Pageof 10